InvestorsHub Logo
icon url

freethemice

12/19/12 4:10 PM

#105035 RE: RRdog #105033

I did notice that ONTY closed at $4.50 yesterday and closed today at $2.19. Thanks for your support.
As an aside, I first invested in Biomira 6 or 7 years ago, but sold out. At the time it was a small Canadian
biotech in Edmonton. At the end of 2007 Biomira changed its name to Oncothyreon, did a 1 for 6 reverse
split, and moved to Seattle.
icon url

The Other Guy

12/19/12 5:14 PM

#105039 RE: RRdog #105033

100% agreement RRdog. You nailed it - specifically point #2.
icon url

biopharm

12/19/12 5:54 PM

#105041 RE: RRdog #105033

" The fact that several potential competitors are failing in their NSCLC trials IMO increases the mathematical probability that PPHM will ultimately find a suitable partner for their drug in this indication (or platform in general)."

I agree RRdog..... and partner by this spring/summer would be good!
icon url

jakedogman1

12/19/12 6:21 PM

#105042 RE: RRdog #105033

with respect to onty value, it was already partnered with single to mid teen royalties based on approval. in march, the market cap was $500 mil plus before the trial was delayed which caused a huge selloff.